Pain Scores and Complications do Not Differ at Three Recovery Position After Liver Biopsy

Overview

Liver biopsy is still used as the gold standard in the diagnosis of many liver diseases. During the observation after liver biopsy, patients are hospitalized on their right side, which is the biopsy side, with the thought that adverse events (complications) such as bleeding or bile leakage will be less. Patients who do not develop complications after 4-6 hours of observation are discharged home. Some of the patients state that the right side-lying position for 4-6 hours is uncomfortable than the biopsy itself, and they prefer to lie on their back. In our study, researchers aim to investigate the rate of complications after biopsy, what recovery position found more acceptable by the patients.

Full Title of Study: “Evaluation of the Pain and Post Procedural Complications of Liver Biopsy Among Different Recovery Positions”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 1, 2021

Detailed Description

Liver biopsy is still used as the gold standard in the diagnosis of many liver diseases. The health practice notification (SUT) makes the diagnosis with liver biopsy mandatory for the treatment of chronic viral hepatitis (Chronic Hepatitis B Inf. And Chronic Hepatitis C Inf.). In daily gastroenterology practice, clinicians frequently perform a liver biopsy for the diagnosis of non-alcoholic fatty liver (NASH), and to a lesser extent, for the diagnosis of Wilson Disease and Hemochromatosis. During the observation after liver biopsy, patients are hospitalized on their right side, which is the biopsy side, with the argument that there will be less bleeding or bile leakage complications. Patients who do not develop complications after 4-6 hours of observation are discharged to their homes. (1) In this study, researchers aimed to investigate the post-biopsy position of patients who were referred to the clinic for liver biopsy, the rate of complications after biopsy, and to what extent the patients found the procedure acceptable according to their post-biopsy position.

Interventions

  • Procedure: Liver Biopsy
    • Liver biopsy is a procedure to obtain small amount of liver by a needle.

Clinical Trial Outcome Measures

Primary Measures

  • Pain scores
    • Time Frame: Immediately after the procedure
    • Patient reported pain scores will be assesed by visual analog scale, minimum score “0” refers no pain and “10” refers worst pain

Secondary Measures

  • Complications
    • Time Frame: within 2 weeks after the procedure
    • Complications such as liver lickage ,bleeding, infection at biopsy site will be recorded

Participating in This Clinical Trial

Inclusion Criteria

1. Cronic hepatitis B İnfection 2. Chronic hepatitis C İnfection 3. NASH 4. DILI 5. Acute or chronic liver damage caused unknown aetiology Exclusion Criteria:

1.Refuse to give written informed consent

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Kocaeli University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Hasan Yılmaz, Assistant Professor – Kocaeli University
  • Overall Contact(s)
    • Hasan Yılmaz, +905058774821, gyrusus@yahoo.com

Citations Reporting on Results

Costa RS, Cardoso AF, Ferreira A, Costa J, Costa D, Fernandes D, Caetano AC. What recovery position should patients adopt after percutaneous liver biopsy? Eur J Gastroenterol Hepatol. 2019 Feb;31(2):253-259. doi: 10.1097/MEG.0000000000001290.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.